| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Schimmel Paul is a Director at aTYR PHARMA INC with holdings across 3 companies. Recent SEC Form 4 filings include 14 buys and 1 sell.
Estimated insider holdings value: $4.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 2025 | ATYR Atyr Pharma Inc | Director | Buy | 1,000,000 | $0.91 | $911,801.16 | +66.3% | -21.7% | - | |
| Jul 24, 2024 | ATYR Atyr Pharma Inc | Director | Buy | 100,000 | $1.85 | $184,613.40 | +9.7% | +73.6% | +187.8% | |
| May 10, 2023 | ATYR Atyr Pharma Inc | Director | Buy | 200,000 | $2.25 | $450,000.00 | +177.0% | -13.3% | -23.9% | |
| Sep 20, 2021 | ATYR Atyr Pharma Inc | Director | Buy | 250,000 | $8.00 | $2,000,000.00 | +8,651% | -22.3% | -71.3% | |
| May 18, 2021 | ATYR Atyr Pharma Inc | Director | Buy | 50,000 | $3.98 | $199,000.00 | +79.3% | +18.4% | -24.2% | |
| May 20, 2020 | ATYR Atyr Pharma Inc | Director | Sell | 8,447 | $3.64 | $30,738.63 | -1.9% | - | - | |
| Feb 10, 2020 | ATYR Atyr Pharma Inc | Director | Buy | 254,000 | $4.25 | $1,079,500.00 | +138.4% | - | - | |
| Nov 26, 2018 | ATYR Atyr Pharma Inc | Director | Buy | 147,225 | $0.54 | $79,795.95 | +20.0% | - | - | |
| Sep 4, 2018 | ATYR Atyr Pharma Inc | Director | Buy | 42,749 | $0.74 | $31,461.07 | +3.0% | - | - | |
| Aug 30, 2018 | ATYR Atyr Pharma Inc | Director | Buy | 164,411 | $0.74 | $121,573.38 | +14.5% | - | - |